Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Safety and efficacy of once-daily modified-release tacrolimus in liver transplant recipients: a multicenter postmarketing surveillance in Japan.

Uemoto S, Abe R, Horike H, So M.

Transplant Proc. 2014 Apr;46(3):749-53. doi: 10.1016/j.transproceed.2013.11.071.

PMID:
24767340
2.

Safety and efficacy of once-daily modified-release tacrolimus in kidney transplant recipients: interim analysis of multicenter postmarketing surveillance in Japan.

Takahashi K, Abe R, Usuki S, So M.

Transplant Proc. 2014;46(2):406-10. doi: 10.1016/j.transproceed.2013.11.072.

PMID:
24655975
3.

Conversion of twice-daily to once-daily tacrolimus is safe in stable adult living donor liver transplant recipients.

Kim SH, Lee SD, Kim YK, Park SJ.

Hepatobiliary Pancreat Dis Int. 2015 Aug;14(4):374-9.

PMID:
26256081
4.
5.

Efficacy, safety, and immunosuppressant adherence in stable liver transplant patients converted from a twice-daily tacrolimus-based regimen to once-daily tacrolimus extended-release formulation.

Beckebaum S, Iacob S, Sweid D, Sotiropoulos GC, Saner F, Kaiser G, Radtke A, Klein CG, Erim Y, de Geest S, Paul A, Gerken G, Cicinnati VR.

Transpl Int. 2011 Jul;24(7):666-75. doi: 10.1111/j.1432-2277.2011.01254.x. Epub 2011 Apr 5.

6.

Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial.

Rostaing L, Bunnapradist S, Grinyó JM, Ciechanowski K, Denny JE, Silva HT Jr, Budde K; Envarsus Study Group.

Am J Kidney Dis. 2016 Apr;67(4):648-59. doi: 10.1053/j.ajkd.2015.10.024. Epub 2015 Dec 22.

7.

A switch from conventional twice-daily tacrolimus to once-daily extended-release tacrolimus in stable kidney transplant recipients.

Hatakeyama S, Fujita T, Yoneyama T, Yoneyama T, Koie T, Hashimoto Y, Saitoh H, Funyu T, Narumi S, Ohyama C.

Transplant Proc. 2012 Jan;44(1):121-3. doi: 10.1016/j.transproceed.2011.11.022.

PMID:
22310594
8.

Conversion of stable kidney transplant recipients from a twice-daily prograf to a once-daily tacrolimus formulation: a short-term study on its effects on glucose metabolism.

Uchida J, Kuwabara N, Machida Y, Iwai T, Naganuma T, Kumada N, Nakatani T.

Transplant Proc. 2012 Jan;44(1):128-33. doi: 10.1016/j.transproceed.2011.11.005.

PMID:
22310596
9.

Once-daily tacrolimus extended release formulation: experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipients.

Florman S, Alloway R, Kalayoglu M, Punch J, Bak T, Melancon J, Klintmalm G, Busque S, Charlton M, Lake J, Dhadda S, Wisemandle K, Wirth M, Fitzsimmons W, Holman J, First MR.

Transplantation. 2007 Jun 27;83(12):1639-42.

PMID:
17589349
10.
11.

Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation.

Doesch AO, Mueller S, Akyol C, Erbel C, Frankenstein L, Ruhparwar A, Ehlermann P, Dengler TJ, Katus HA.

Drug Des Devel Ther. 2013 Oct 21;7:1253-8. doi: 10.2147/DDDT.S52820. eCollection 2013.

12.

Safety and efficacy of conversion from twice-daily tacrolimus (prograf) to once-daily prolonged-release tacrolimus (graceptor) in stable kidney transplant recipients.

Nakamura Y, Hama K, Katayama H, Soga A, Toraishi T, Yokoyama T, Kihara Y, Jojima Y, Konno O, Iwamoto H, Takeuchi H, Hirano T, Shimazu M.

Transplant Proc. 2012 Jan;44(1):124-7. doi: 10.1016/j.transproceed.2011.11.051.

PMID:
22310595
13.

Long-term follow-up of stable kidney transplant recipients after conversion from tacrolimus twice daily immediate release to tacrolimus once-daily prolonged release: a large single-center experience.

Slatinska J, Rohal T, Wohlfahrtova M, Viklicky O.

Transplant Proc. 2013 May;45(4):1491-6. doi: 10.1016/j.transproceed.2012.11.017.

PMID:
23726604
14.

Conversion of stable liver transplant recipients from a twice-daily Prograf-based regimen to a once-daily modified release tacrolimus-based regimen.

Florman S, Alloway R, Kalayoglu M, Lake K, Bak T, Klein A, Klintmalm G, Busque S, Brandenhagen D, Lake J, Wisemandle K, Fitzsimmons W, First MR.

Transplant Proc. 2005 Mar;37(2):1211-3.

PMID:
15848672
15.

Once-daily tacrolimus extended-release formulation: 1-year post-conversion in stable pediatric liver transplant recipients.

Heffron TG, Pescovitz MD, Florman S, Kalayoglu M, Emre S, Smallwood G, Wisemandle K, Anania C, Dhadda S, Sawamoto T, Keirns J, Fitzsimmons W, First MR.

Am J Transplant. 2007 Jun;7(6):1609-15.

16.

Once-daily prolonged release tacrolimus in liver transplantation: Experts' literature review and recommendations.

Coilly A, Calmus Y, Chermak F, Dumortier J, Duvoux C, Guillaud O, Houssel-Debry P, Neau-Cransac M, Stocco J.

Liver Transpl. 2015 Oct;21(10):1312-21. doi: 10.1002/lt.24228. Review.

18.

Successful conversion from twice-daily to once-daily tacrolimus in liver transplantation: observational multicenter study.

Dopazo C, Rodriguez R, Llado L, Calatayud D, Castells L, Ramos E, Molina V, García R, Fabregat J, Charco R.

Clin Transplant. 2012 Jan-Feb;26(1):E32-7. doi: 10.1111/j.1399-0012.2011.01521.x. Epub 2011 Sep 30.

PMID:
21958123
19.

Early Conversion From Twice-Daily Tacrolimus to Prolonged-Release Tacrolimus in Liver Transplantation: A Single-Center Experience.

Ogura Y, Imai H, Kamei H, Hori T, Kurata N, Onishi Y.

Ann Transplant. 2016 Jul 19;21:448-55.

20.

Orthotopic liver transplantation using low-dose tacrolimus and sirolimus.

McAlister VC, Peltekian KM, Malatjalian DA, Colohan S, MacDonald S, Bitter-Suermann H, MacDonald AS.

Liver Transpl. 2001 Aug;7(8):701-8.

Supplemental Content

Support Center